Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hinge Health (HNGE) Common Equity (2023 - 2025)

Hinge Health's Common Equity history spans 3 years, with the latest figure at $178.7 million for Q4 2025.

  • For Q4 2025, Common Equity rose 141.11% year-over-year to $178.7 million; the TTM value through Dec 2025 reached $178.7 million, up 141.11%, while the annual FY2025 figure was $178.7 million, 141.11% up from the prior year.
  • Common Equity for Q4 2025 was $178.7 million at Hinge Health, down from $208.0 million in the prior quarter.
  • Across five years, Common Equity topped out at $208.0 million in Q3 2025 and bottomed at -$462.6 million in Q2 2024.
  • The 3-year median for Common Equity is -$424.0 million (2023), against an average of -$174.6 million.
  • The largest annual shift saw Common Equity dropped 2.49% in 2024 before it soared 145.04% in 2025.
  • A 3-year view of Common Equity shows it stood at -$424.0 million in 2023, then fell by 2.49% to -$434.6 million in 2024, then skyrocketed by 141.11% to $178.7 million in 2025.
  • Per Business Quant, the three most recent readings for HNGE's Common Equity are $178.7 million (Q4 2025), $208.0 million (Q3 2025), and $173.8 million (Q2 2025).